Bone-targeted enzyme replacement therapy

Asfotase alfa (أسفوتاز ألفا)

Asfotase alfa is a manufactured alkaline-phosphatase enzyme designed to bind to bone and replace the missing activity in hypophosphatasia. It is used long term for bone manifestations of disease that began in childhood, under a team experienced in metabolic bone disorders.

This medicine is used under close medical supervision, usually by a specialist. Never start, stop or change it without your doctor.

What it is used for

  • Treating bone manifestations of hypophosphatasia that began in childhood
  • Improving bone mineralisation, growth and mobility according to specialist assessment
  • Reducing skeletal and breathing complications related to poorly mineralised bone

How it is used

  • Use it only under the skin and on the plan set by an experienced doctor; never change the amount or schedule yourself
  • The team trains the patient or carer to prepare the injection, inspect the solution and inject safely
  • Rotate among permitted injection areas and avoid red, hardened or damaged skin
  • Do not mix it with another medicine or use a vial for more than one patient
  • Attend growth, bone, dental, eye and kidney follow-up arranged by the team

Possible side effects

  • Pain, redness, itching or swelling at the injection site
  • Bruising, headache or limb pain
  • Fatty lumps or loss of tissue under the skin after repeated injections
  • Fever, irritability or nausea
  • A rare severe allergic reaction

Who should not use it

  • Do not use after a severe reaction to asfotase alfa or a product ingredient if the allergy cannot be controlled
  • Do not inject it into a vein or muscle
  • Do not use it for common osteoporosis or osteomalacia from other causes

Before and while using it

  • Breathing difficulty, facial swelling or a widespread rash after injection may be a severe allergy and needs urgent help
  • Repeated injections can cause lasting changes in fat under the skin; rotate sites and report every lump or hollow
  • Calcium deposits can occur around the eyes or in the kidneys; regular checks are needed even without symptoms
  • Early fusion of skull bones can occur in children with the disease; the team monitors head shape and pressure within the skull
  • Treatment interferes with some alkaline-phosphatase laboratory tests and can give misleading results; tell the laboratory that you use it
  • Choosing the wrong vial or calculating the amount incorrectly can cause harm; check the label and team plan before every injection

Medicine interactions

  • No important medicine interactions are established, but tell the team about every medicine and supplement you use
  • Asfotase alfa can interfere with laboratory tests that rely on alkaline phosphatase, so the laboratory must be informed
  • Do not mix it with any other product in the same syringe

Pregnancy and breastfeeding

  • Pregnancy data are limited; tell your team if you are pregnant or planning pregnancy so it can decide whether treatment need outweighs unknown risk
  • It is not known whether it enters milk; the doctor discusses the benefit of breastfeeding and the mother's need for treatment

How to store it

  • Keep vials refrigerated in the original carton, protected from light, and do not freeze or shake them
  • Remove a vial when preparing to inject and follow the product leaflet for use and disposal of any remainder

Get medical help straight away if

  • Your face, lips or tongue swell, or you find it hard to breathe.
  • You get a severe rash, blistering or peeling skin.
  • A side effect worries you or doesn’t go away: contact your doctor or pharmacist.

Questions about this medicine?

Talk to a doctor by video, or send your question by text.

Source: Standard international medicine references

This guide is general information and doesn’t replace advice from your doctor or pharmacist. Don’t start, stop or change a medicine without asking them, and always read the leaflet in the pack.